DOCSLIB.ORG

R & D Intensity and Dividend Policy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
R & D Intensity and Dividend Policy sustainability Article R & D Intensity and Dividend Policy: Evidence from South Korea’s Biotech Firms Namryoung Lee 1 and Jaehong Lee 2,* 1 School of Business, Korea Aerospace University, Goyang 10540, Korea 2 College of Business, Sangmyung University, Seoul 03016, Korea * Correspondence: [email protected] Received: 31 July 2019; Accepted: 31 August 2019; Published: 4 September 2019 Abstract: In this paper, we examine the relation between a firm’s research and development (R & D) intensity and dividend payout policy with a focus on biotech firms in a sample of 18,253 firm-year observations in South Korea. We find that biotech firms’ R & D intensity is negatively related to dividend payout. Furthermore, for biotech firms, increased internal cash holding accomplished via a lower dividend policy is positively associated with long-term corporate value. In particular, this study reports that the relation between biotech firms’ cash holding and corporate firm value is significantly positive in firms with high stock dividends. Moreover, it shows that non-biotech firms in the maturity stage of the corporate lifecycle tend to distribute cash dividends, a practice that is relatively uncommon among biotech firms in an R & D steady state. Keywords: R & D intensity; South Korea’s biotech firms; cash holding; dividend policy; firm value 1. Introduction “Today’s business environment, perhaps more than at any other time in modern history, demands a continuous search for new sources of competitive advantage for sustainable growth” [1]. As competition grows, it becomes ever more vital for companies to discover new advantages. One path of discovery is through innovation, which is driven by investment in research and development (R & D). The quality of R & D, e.g., its efficiency and expertise, is essential to the sustainable success of the firm, because a shortening time-to-market timeline has accelerated the need to produce new products [2]. Therefore, management must adeptly assess the financial situation within a firm and determine the appropriate amount of resources to invest in R & D. One decision management must make is whether to fund short-term projects for the purpose of making immediate profits or focus on longer-term projects that may generate a more sustainable success. Management must decide which strategy to employ when investing resources, as the decision partially determines the company’s short-term and long-term value, which has an effect on dividend payments and stock prices [3]. The dividend policy of a firm is a complex financial decision and one of the most highly debated issues in corporate finance literature in both developed and emerging markets. When deciding on a policy, management must consider the amount of earnings that will be reserved and distributed as well as the ways in which the supply shortages that may occur during dividend distribution will be supplemented. Before the financial crisis, the most commonly practiced dividend policy was to distribute low dividends regardless of earnings. However, through the improvement of corporate governance, management transparency and shareholder rights were enhanced. This increased the effect of a firm’s dividend policy on firm value by considering both current earnings and future profitability [4]. Sustainability 2019, 11, 4837; doi:10.3390/su11184837 www.mdpi.com/journal/sustainability Sustainability 2019, 11, 4837 2 of 21 Social interest in dividend policy has increased due to the recent phenomenon of low growth and interest rates. According to Korea Stock Exchange, 755 corporations announced cash dividends from December 2015 to February 2016, 52 more than in the previous year. Total dividends also increased by 3.9 trillion won to a total of 18.0 trillion won. Likewise, there is a continuous increase in the number of cases of domestic firms returning shareholder profits with cash dividends. However, among pharmaceutical and biotech industries, this tendency is reversed. Recently, in the years following a boom in R & D investment in new drugs, these firms seem to be focusing on securing R & D funds for future sustainable growth rather than focusing on dividends. In a 2018 study, the 20 highest R & D-investing firms of all listed pharmaceutical or biotech firms in 2016 were analyzed to find the correlation between cash dividends and R & D investment [5]. Many of those firms either reduced cash dividends or did not distribute them at all. The highest investing firm, Celltrion, invested 39% of its sales, or 264 billion won. Celltrion distributed cash dividends for three years, from 2010 to 2012, but has not distributed them since. Following Celltrion, Hanmi Pharmaceutical, which is second in R & D investment (162.6 billion won), only issued cash dividends once during the 2010s. That was in 2015, when Hanmi Pharmaceutical reached an all-time high in the amount of technology exports. This led experts to determine that domestic pharmaceutical or biotech firms that focus on domestic demands such as developing generics are now inclined to invest stockpiled cash in R & D rather than on dividends. In other words, as top firms are spurring R & D for entrance to the global market, they are expanding R & D investment rather than returning cash to shareholders. Management plays an important role in corporate decision making for the benefits of shareholders [6,7]. Its foremost goal is to maximize the value of the firm and increase the market value of its stock [8,9]. In general, managers appear to firmly believe that the market values companies with a stable dividend policy [10]. However, there is evidence that firms that have positive investment opportunities either offer no payout or pay out very little compared to other firms, and that trend is spreading to all firms regardless of investment opportunities [11]. These findings suggest that the ideal dividend policy for firms with positive growth prospects is one in which cash is channeled to corporate insiders by lowering or eliminating the dividend. The biotechnology industry is characterized by particularly high-risk, long-term development and lengthy commercialization periods, in part because it is a rapidly-evolving, high-tech industry that depends on entrepreneurialism and innovation [12]. The innovation of these firms, which is generally believed to be excellent, is measured by the intensity of R & D. That innovation is driven by investment in R & D, which increases both profitability and future growth opportunities of the firm [13]. Due to the increasingly global biotech market, firms must substantially invest in R & D [14]. With this in mind, a biotech company in a small country such as Korea requires a consistent, low-cost source of large amounts of capital in order to be sustainably successful. Relatively little research has been conducted on the unique relationship between intensity of R & D and dividend policy among biotech firms. Regarding this, the study conducted its empirical analysis by using 18,253 firm-year observations (which included 1667 biotech firms for the period from 2000 to 2017 in South Korea) and discovered the following outcomes. First, we found there to be a negative correlation between R & D intensity and dividend payout among biotech firms. Second, internal cash holding is positively correlated to the long-term value of the firm. Furthermore, stock dividends are the only effective tool to satisfy investor demand for dividends while retaining internal funds. This study also found that, while firms outside of the biotech industry often distribute cash dividends when they reach the maturity stage of the corporate lifecycle, that is not the case for biotech firms in an R & D steady state. Due to delayed profitability resulting from large-scale, consistent R & D investment and the long-term lifecycle within the industry, the relatively weak connection between biotech firms with high R & D intensity and dividend payouts are observed at every level of maturity. Finally, we found that firms with high R & D intensity increase firm value through internal funds and a policy of Sustainability 2019, 11, 4837 3 of 21 low dividend payout. Several additional tests were conducted to determine that the findings of this study were still valid by the robust regressions in estimating specifications. This study makes the following contributions. First, our study is one of the first to examine the consequences on the dividends of the biotech firms with high R & D intensity. Prior studies report that R & D drives innovation and has a persistent, positive long-term effect on firm value [15], and they focus primarily on the effect of R & D on firm value. To achieve this, continuously funded R & D investment is crucial. However, the literature does not provide much evidence on the financing sources for aiding R & D activity. By reporting R & D intensity is negatively correlated to dividend payout even if the firms have excess cash holdings, this study contributes to the literature that attempts to link biotech companies with high R & D to financing sources through dividends policy. Second, this study offers an in-depth analysis by considering various types of dividends and industries. Most studies have concentrated only on the cash dividends and general dividend tendency of the firms, implying that firms with high profitability are likely to distribute the earnings in the form of dividends to satisfy shareholders, but the opposite is true for biotech firms. The dividend policies of biotech firms with high growth opportunities and R & D intensity differ in that, since external financing through the capital market can reveal sensitive information about the firm to the competitors, many R & D-intensive biotech firms choose to finance internally via reducing dividends. This paper is structured as follows. In Section2, we review previous literature—mainly related to biotech firms and the effect of R & D intensity of dividend policy—and present our hypotheses. In Section3, we share our research design and dataset, which was used to test our hypotheses.
Load more

Recommended publications
  • Comparison of New Implantation of Cardiac Implantable Electronic
    www.nature.com/scientificreports OPEN Comparison of new implantation of cardiac implantable electronic device between tertiary and non‑tertiary hospitals: a Korean nationwide study Seungbong Han1, Gyung‑Min Park2, Yong‑Giun Kim2*, Ki Won Hwang3, Chang Hee Kwon4, Jae‑Hyung Roh5, Sangwoo Park2, Ki‑Bum Won2, Soe Hee Ann2, Shin‑Jae Kim2 & Sang‑Gon Lee2 This study compared the characteristics and mortality of new implantation of cardiac implantable electronic device (CIED) between tertiary and non‑tertiary hospitals. From national health insurance claims data in Korea, 17,655 patients, who underwent frst and new implantation of CIED between 2013 and 2017, were enrolled. Patients were categorized into the tertiary hospital group (n = 11,560) and non‑tertiary hospital group (n = 6095). Clinical outcomes including in‑hospital death and all‑cause death were compared between the two groups using propensity‑score matched analysis. Patients in non‑tertiary hospitals were older and had more comorbidities than those in tertiary hospitals. The study population had a mean follow‑up of 2.1 ± 1.2 years. In the propensity‑score matched permanent pacemaker group (n = 5076 pairs), the incidence of in‑hospital death (odds ratio [OR]: 0.76, 95% confdence interval [CI]: 0.43–1.32, p = 0.33) and all‑cause death (hazard ratio [HR]: 0.92, 95% CI 0.81–1.05, p = 0.24) were not signifcantly diferent between tertiary and non‑tertiary hospitals. These fndings were consistently observed in the propensity‑score matched implantable cardioverter‑ defbrillator group (n = 992 pairs, OR for in‑hospital death: 1.76, 95% CI 0.51–6.02, p = 0.37; HR for all‑cause death: 0.95, 95% CI 0.72–1.24, p = 0.70).
    [Show full text]
  • Extended Deterrence and Strategic Stability in East Asia: AY19 Strategic Deterrence Research Papers (Vol I)
    ExtendedFuture Warfare Deterrence Series No. and 10203040 DefendingAvoidingStrategicTheThe “WorriedAnthrax thePanic Stability American Vaccine Well”and in Keeping ResponseEast Debate: Homeland Asia: the A MedicalPortsAY19 Opento StrategicReview CBRN1993-2003 in a Events:forChemical Deterrence Commanders and BiologicalResearchAnalysis Threat andPapers Solu�onsEnvironment (Vol I) A Literature Review TanjaLieutenantRandallMajor M. Korpi J.Richard ColonelLarsen andEdited A.Christopherand Fred Hersack,by: Patrick P. Stone, USAF D.Hemmer EllisUSAF Dr. Paige P. Cone Dr. James Platte Dr. R. Lewis Steinhoff United States Air Force Center for Strategic Deterrence Studies 30204010 Maxwell Air Force Base, Alabama Extended Deterrence and Strategic Stability in East Asia: AY19 Strategic Deterrence Research Papers (Vol I) Edited by Dr. Paige P. Cone Dr. James E. Platte Dr. R. Lewis Steinhoff USAF Center for Strategic Deterrence Studies 125 Chennault Circle Maxwell Air Force Base, Alabama 36112 August 2019 Table of Contents Chapter Page Disclaimer ..………………………………………………..….……….….……...ii Preface ..…………………………………………………….………..….….…... iii Chapter 1. Introduction ……………………………………………….….………1 Chapter 2. Assuring the Republic of Korea through Nuclear Sharing: A Blueprint for an Asian Ally Col. Jordan E. Murphy, U.S. Air Force………………………..…………….……5 Chapter 3. Missile Defense in South Korea Lt. Col. Elizabeth T. Benedict, U.S. Air Force…………………...……………….…23 Chapter 4. United States Air Force Posture: Impacts to Japanese Assurance in the Indo-PACOM AOR Maj. Jonathan P.
    [Show full text]
  • ECDC/EFSA Joint Report: Avian Influenza Overview October
    SCIENTIFIC REPORT APPROVED: 29 September 2017 doi: 10.2903/j.efsa.2017.5018 Avian influenza overview October 2016–August 2017 European Food Safety Authority, European Centre for Disease Prevention and Control, European Union Reference Laboratory for Avian influenza, Ian Brown, Paolo Mulatti, Krzysztof Smietanka, Christoph Staubach, Preben Willeberg, Cornelia Adlhoch, Denise Candiani, Chiara Fabris, Gabriele Zancanaro, Joana Morgado and Frank Verdonck Abstract The A(H5N8) highly pathogenic avian influenza (HPAI) epidemic occurred in 29 European countries in 2016/2017 and has been the largest ever recorded in the EU in terms of number of poultry outbreaks, geographical extent and number of dead wild birds. Multiple primary incursions temporally related with all major poultry sectors affected but secondary spread was most commonly associated with domestic waterfowl species. A massive effort of all the affected EU Member States (MSs) allowed a descriptive epidemiological overview of the cases in poultry, captive birds and wild birds, providing also information on measures applied at the individual MS level. Data on poultry population structure are required to facilitate data and risk factor analysis, hence to strengthen science-based advice to risk managers. It is suggested to promote common understanding and application of definitions related to control activities and their reporting across MSs. Despite a large number of human exposures to infected poultry occurred during the ongoing outbreaks, no transmission to humans has been identified. Monitoring the avian influenza (AI) situation in other continents indicated a potential risk of long-distance spread of HPAI virus (HPAIV) A(H5N6) from Asia to wintering grounds towards Western Europe, similarly to what happened with HPAIV A(H5N8) and HPAIV A(H5N1) in previous years.
    [Show full text]
  • The Emergence and Decennary Distribution of Clade 2.3.4.4 HPAI H5nx
    microorganisms Review The Emergence and Decennary Distribution of Clade 2.3.4.4 HPAI H5Nx Khristine Joy C. Antigua, Won-Suk Choi, Yun Hee Baek and Min-Suk Song * College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Chungbuk 28644, Korea; [email protected] (K.J.C.A.); [email protected] (W.-S.C.); [email protected] (Y.H.B.) * Correspondence: [email protected] Received: 8 May 2019; Accepted: 28 May 2019; Published: 29 May 2019 Abstract: Reassortment events among influenza viruses occur naturally and may lead to the development of new and different subtypes which often ignite the possibility of an influenza outbreak. Between 2008 and 2010, highly pathogenic avian influenza (HPAI) H5 of the N1 subtype from the A/goose/Guangdong/1/96-like (Gs/GD) lineage generated novel reassortants by introducing other neuraminidase (NA) subtypes reported to cause most outbreaks in poultry. With the extensive divergence of the H5 hemagglutinin (HA) sequences of documented viruses, the WHO/FAO/OIE H5 Evolutionary Working Group clustered these viruses into a systematic and unified nomenclature of clade 2.3.4.4 currently known as “H5Nx” viruses. The rapid emergence and circulation of these viruses, namely, H5N2, H5N3, H5N5, H5N6, H5N8, and the regenerated H5N1, are of great concern based on their pandemic potential. Knowing the evolution and emergence of these novel reassortants helps to better understand their complex nature. The eruption of reports of each H5Nx reassortant through time demonstrates that it could persist beyond its usual seasonal activity, intensifying the possibility of these emerging viruses’ pandemic potential.
    [Show full text]
  • Annual Report of the Sri Lanka Export Development Board for the Year 2017
    ANNUAL REPORT 2017 SRI LANKA EXPORT DEVELOPMENT BOARD 128 18-03-2019 Hon. Malick Samarawickrama Ministry of Development Strategies & International Trade, 30th Floor, West Tower, World Trade Centre, Colombo 01. Hon. Sir Annual Report and Statement of Accounts – 2017 I am pleased to present on behalf of the Board of Directors, the Annual Report of the SLEDB together with the following documents for 2017 in term of section 13 (2) of the Finance Act No.38 of 1971. - Chairperson’s Report - Statement of Accounts - Auditor General’s Report Yours faithfully, Indira Malwatte Chairperson & CE SRI LANKA EXPORT DEVELOPMENT BOARD 129 SENIOR MANAGEMENT STAFF - 2017 Chairperson and Chief Executive - Mrs. Indira Malwatte Director General - Mrs. J. Siriward a na Addl. Director General - Finance & - Ms. R. M. P. Hewaliyanage Administration (Up to March 2017) - Mrs. P. K. Sumithrarachchi (From 03.04.2017) Addl. Director General - Development - Mr. D. Jayawardane (From 03.04.2017) Finance Division - Mrs. P. K. Sumithrarachchi (Up to 02.04.2017) - Ms. G.M. Herath (Director) (From 16.10.2017) Human Resources Development Division - Mr. K. K. R. Kannangara (Director) Trade Facilitation & Trade Information - Mr. S. R. P. Indrakeerthi (Director) Division Information Technology Division - Mrs. I.C. Alahapperuma (Director) Export Agriculture Division - Mrs. P.V.A.M. Badd egamage (Director) Regional Development Division - Mr. T.D. Athapaththu (Director) (Up to 31.03.2017) - Mr. K.M.R.P. Fernando (Actg. Director) (From 01.06.2017) Policy & Strategic Planning Division - Mrs. U.K.D. Wegapitiya (Director) Industrial Products Division - Ms. C. Dissanayake (Director) Export Services Division - Mr. M.K.S.K.
    [Show full text]
  • Status of Coral Reefs in East Asian Seas Region: 2018
    Status of Coral Reefs in East Asian Seas Region: 2018 Edited by KIMURA Tadashi, TUN Karenne and CHOU Loke Ming Front Cover: Shallow coral reef in Sekisei Lagoon, Okinawa, Japan ( C Tadashi Kimura, 2017 ) Back Cover: Shallow coral reef in Sekisei Lagoon, Okinawa, Japan ( C Tadashi Kimura, 2017) Citation: Kimura, T. Tun, K and Chou, L.M. (2018). Status of coral reefs in East Asian Seas Region: 2018. Ministry of the Environment of Japan and Japan Wildlife Research Center, Tokyo, Japan, 58 p. C Ministry of the Environment: 1-2-2 Kasumigaseki, Chiyoda, Tokyo 100-8975, Japan Telephone: (+81) 3 3581 3351 www.env.go.jp Japan Wildlife Research Center 3-3-7 Koto-bashi, Sumida, Tokyo 130-8606, Japan Telephone (+81) 3 6659 6332 Facsimile (+81) 3 6659 5633 www.jwrc.or.jp This Report has been edited and organized by Japan Wildlife Research Center by contract with the Ministry of Environment. However, the analyses and recommendations in this Report are the fruit of collaborative efforts by the GCRMN National Coordinators of countries in East Asian Seas Region and do not necessarily reflect views of the Ministry of Environment. Each author is responsible for his/her article in the report. FOREWORD This regional report is a direct response to the International Coral Reef Initiative (ICRI) strategy on research and monitoring determined in the ‘Call to Action’ developed in Dumaguete City, The Philippines in 1995 which promotes cooperation among national research programs and monitoring networks. Responding to the ‘Call to Action’, the Ministry of the Environment of Japan and the Japan Wildlife Research Center, in association with the regional coordinators on coral monitoring for Northeast and Southeast Asia have worked with national coral reef monitoring coordinators to produce a regional status of coral reefs since 2004.
    [Show full text]
  • Tykání and Vykání in Korean
    Palacký University Olomouc General Linguistics and Theory of Communication Grammatical Expressions of Politeness in Czech and Korean: Tykání and Vykání in Korean Youngran BAŠTANOVÁ KWAK (Youngran KWAK) Ph.D. Dissertation Supervisor: prof. PhDr. Jan Kořenský, DrSc. Consultant: doc. Mgr. Dan Faltýnek, Ph.D. Olomouc 2021 Declaration I hereby declare that I have written this dissertation by myself. I have listed all the literature and sources used in the text. Date: April 26, 2021 Signature: 2 Acknowledgements I would like to thank prof. PhDr. Jan Kořenský, DrSc. for being my supervisor, and doc. Mgr. Dan Faltýnek, Ph.D. for being my consultant and giving me invaluable advice. I am grateful to my friend, who is also my Czech language teacher, Mgr. Michaela Kopečková, Ph.D. for her insightful comments on the Czech language and culture. I am also indebted to my old friends in Korea: special thanks to Samantha Twadell for helping me whenever I have questions about English, and Sunjoo Cho for taking some photos in Seoul for me, which I displayed in Appendix. Last but not least, my sincere thanks go to my family for their love and warm support, especially to my husband Radim, and my parents. To Radim, I also want to express my appreciation for correcting my self-transcription of the Czech audio in my work. 3 Abstract in English Grammatical Expressions of Politeness in Czech and Korean: Tykání and Vykání in Korean This dissertation is a contrastive study of grammatical and lexical expressions of Czech and Korean politeness. It focuses primarily on vykání and tykání in contemporary Czech, and jon-daes-mal and ban-mal in contemporary Korean.
    [Show full text]
  • Evolution, Global Spread, and Pathogenicity of Highly Pathogenic Avian Influenza H5nx Clade 2.3.4.4
    Review J Vet Sci 2017, 18(S1), 269-280ㆍhttps://doi.org/10.4142/jvs.2017.18.S1.269 JVS Evolution, global spread, and pathogenicity of highly pathogenic avian influenza H5Nx clade 2.3.4.4 Dong-Hun Lee1, Kateri Bertran1, Jung-Hoon Kwon2, David E. Swayne1,* 1U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA 30605, USA 2Avian Diseases Laboratory, College of Veterinary Medicine, Konkuk University, Seoul 05029, Korea Novel subtypes of Asian-origin (Goose/Guangdong lineage) H5 highly pathogenic avian influenza (HPAI) viruses belonging to clade 2.3.4, such as H5N2, H5N5, H5N6, and H5N8, have been identified in China since 2008 and have since evolved into four genetically distinct clade 2.3.4.4 groups (A–D). Since 2014, HPAI clade 2.3.4.4 viruses have spread rapidly via migratory wild aquatic birds and have evolved through reassortment with prevailing local low pathogenicity avian influenza viruses. Group A H5N8 viruses and its reassortant viruses caused outbreaks in wide geographic regions (Asia, Europe, and North America) during 2014–2015. Novel reassortant Group B H5N8 viruses caused outbreaks in Asia, Europe, and Africa during 2016–2017. Novel reassortant Group C H5N6 viruses caused outbreaks in Korea and Japan during the 2016–2017 winter season. Group D H5N6 viruses caused outbreaks in China and Vietnam. A wide range of avian species, including wild and domestic waterfowl, domestic poultry, and even zoo birds, seem to be permissive for infection by and/or transmission of clade 2.3.4.4 HPAI viruses. Further, compared to previous H5N1 HPAI viruses, these reassortant viruses show altered pathogenicity in birds.
    [Show full text]
  • The Year in Trade 2017
    United States International Trade Commission The Year in Trade 2017 Operation of the Trade Agreements Program 69th Report August 2018 Publication Number: 4817 United States International Trade Commission Commissioners David S. Johanson, Chairman Irving A. Williamson Meredith M. Broadbent Rhonda K. Schmidtlein Jason E. Kearns Catherine DeFilippo Director, Office of Operations William Powers Director, Office of Economics Address all communications to Secretary to the Commission United States International Trade Commission Washington, DC 20436 The Year in Trade 2017 Operation of the Trade Agreements Program 69th Report August 2018 Publication Number: 4817 This report was prepared principally by: Project Leader Joanne Guth, Office of Economics Deputy Project Leader Tamara Gurevich, Office of Economics Office of Economics Justino De La Cruz, Pamela Davis, Stephanie Fortune-Taylor, Alexander Hammer, Lin Jones, Grace Kenneally, Alissa Tafti, Edward Wilson, and Heather Wickramarachi Office of General Counsel William W. Gearhart Office of Industries Arthur Chambers, Natalie Hanson, Tamar Khachaturian, Sarah Oliver, and Laura Rodriguez Office of Investigations Brenna Cole, Mary Messer, and Salvatore Mineo Office of Tariff Affairs and Trade Agreements Donnette Rimmer and Daniel Shepherdson Office of Unfair Import Investigations David Lloyd Office of Analysis and Research Services Maureen Letostak, David Lundy, and Laura Thayn Editorial Review Judy Edelhoff and Peg Hausman Statistical Review Russell Duncan Content Reviewer Janis Summers Administrative Support Nabil Abbyad and Meryem Demirkaya Help Desk and Customer Service Division (CIO) Under the direction of Arona Butcher, Chief Country and Regional Analysis Division Office of Economics Preface This report is the 69th in a series of annual reports submitted to the U.S.
    [Show full text]
  • PGPF 2019 All 3 Outcome Documents
    ! PyeongChang, Korea, 9-11 Feb. 2019 We are determined to foster peaceful, just and inclusive societies which are free from fear and violence. There can be no sustainable development without peace and no peace without sustainable development. (Preamble of UN 2030 Agenda for Sustainable Development) Outcome Documents 1. PyeongChang Declaration for Peace 2019 : Sustainable Future for All: Ending War, Guaranteeing Peace 2. Resolution for Sustaining Peace Process in Korean Peninsula and Northeast Asia 3. Framework of PyeongChang Agenda for Peace (PCAP) 2030 WWW.PGPF.Kr [email protected] !1 PyeongChang Declaration for Peace 2019 Sustainable Future for All: Ending War, Guaranteeing Peace On February 9-11, 2019 in PyeongChang, more than 500 people from 50 countries and 200 organizations gathered to review the crises and prospects of peace. In a country where the agony of war and deep division spans seven decades, participants have collectively sought ways to end the long, tragic tradition and prepare for a sustainable future. After six months of preparation, a civil-society-led Global Peace Forum was held with support from Gangwon Province, PyeongChang Municipality, Korea International Cooperation Agency (KOICA), and the Korean people. The astonishing peace process ushered in by the Candlelight Revolution and manifested at the 2018 PyeongChang Winter Olympics and Paralympic became a great inspiration for people around the world. Breaking through thick historical and political barriers erected during the previous century, the new process presents a ground-breaking model for peacebuilding efforts. By participating in sporting events, cultural and art exhibits collectively, we consolidate efforts for lasting peace. These steps are necessary to build trust and show there is a commonality for peace talks and processes.
    [Show full text]
  • Table of Contents
    News Across Asia “Pharmacoeconomics and Outcomes Research Quarterly Serving to Inform Health Policy in Asia-Pacific” ISPOR Asia Consortium Leadership Volume 6 Number 1 (April-July 2017) ISSN 2308-1945 Executive Committee Table of Contents 2016-2018 Chair Health Policy in Asia-Pacific Isao Kamae, MD, DrPH University of Tokyo Patient Involvement in Health Technology Assessment in Asia- Tokyo, Japan Introduction, China, Japan, South Korea and Taiwan Health Technology Assessment and Its Application in Vietnam 2016-2018 Chair-Elect Kun Zhao, PhD, MD, MHSc Regional Health Initiatives China National Health 2nd International PEOR Conference in Andhra Pradesh, India Development Research Center Beijing, China Workshop in Kolkata, India Indonesia workshops and publication 2016-2018 Past Chair Surachat Ngorsuraches, PhD Asia Consortium at ISPOR Boston South Dakota State University Asia Consortium meetings and forums Brookings, ND, USA Advisory Committee Outcomes Research Value in Health Regional Issues (ViHRI) Vol 12, May 2017 – focusing on Asia 2017-2019 Chair Bruce Crawford, MPH, MA ISPOR 6th Latin America Conference inVentiv Health Register at the conference website Tokyo, Japan 2017-2019 Chair-Elect Member-Reported News Chee-Jen Chang, PhD Stent Price Regulations in India Chang Gung University HTA Horizons Expanding within the Eurasian Economic Union Taipei, Taiwan Drug Catalogue Selection in China Establishing Cost-effectiveness Threshold for Malaysia 2017-2019 Past Chair Vivian WY Lee, PharmD New Health Policies in South Korea
    [Show full text]
  • Current Affairs June 2017 PDF Capsule
    Current Affairs June 2017 PDF Capsule Current Affairs PDF: June 2017 Current Affairs for Competitive Exam Contents INDIAN AFFAIRS ............................................................................................................................................................ 3 PLACES IN NEWS ......................................................................................................................................................... 26 FOREIGN VISITS .......................................................................................................................................................... 30 INTERNATIONAL AFFAIRS....................................................................................................................................... 38 SUMMITS & CONFERENCES ..................................................................................................................................... 47 RANKINGS & REPORTS ............................................................................................................................................. 51 BANKING & FINANCE ................................................................................................................................................. 61 BUSINESS ....................................................................................................................................................................... 77 AWARDS & RECOGNITIONS ....................................................................................................................................
    [Show full text]